SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-028601
Filing Date
2011-05-12
Accepted
2011-05-12 16:35:45
Documents
5
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-10843_110q.htm 10-Q 781883
2 EX-31.1 a11-10843_1ex31d1.htm EX-31.1 11970
3 EX-31.2 a11-10843_1ex31d2.htm EX-31.2 12500
4 EX-32.1 a11-10843_1ex32d1.htm EX-32.1 5467
5 EX-32.2 a11-10843_1ex32d2.htm EX-32.2 5445
  Complete submission text file 0001104659-11-028601.txt   818250
Mailing Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703 919 313-4760
TRANZYME INC (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35119 | Film No.: 11836233
SIC: 2834 Pharmaceutical Preparations